Dr. Lal PathLabs Limited
LALPATHLAB
株式のランク
#4532
Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health... Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health assessment services, operating both domestically in India and across international borders. The company manages a comprehensive network of laboratories dedicated to conducting pathological investigations across various specialized fields. These include biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, in addition to other general pathological and radiological studies. Beyond its core testing operations, Dr. Lal PathLabs also offers laboratory staff training, technical support, and full-scale lab management services. As of March 31, 2022, its widespread infrastructure included 277 clinical laboratories, notably a National Reference Lab located in Delhi and a Regional Reference Lab in Kolkata. This is further bolstered by 4,731 patient service centers and 10,599 sample collection points. Founded in 1949, Dr. Lal PathLabs Limited maintains its corporate base in Gurugram, India.
株価
$20.51
時価総額
$3.43B
変化（1日）
0.79%
変化（1年）
15.11%
国
IN
取引 Dr. Lal PathLabs Limited (LALPATHLAB)
カテゴリー
Healthcare
Dr. Lal PathLabs Limited（LALPATHLAB）の収益
Jun 2026 時点の収益 TTM: $319.03M
Dr. Lal PathLabs Limited の最新の財務報告によると、現在の収益 (TTM) は $319.03M です。2024 年には $267.04M の収益があり、これは 2023 年の $245.42M と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Dr. Lal PathLabs Limited の収益履歴（2011 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $319.03M | 10.85% |
| 2025 | $287.79M | 7.77% |
| 2024 | $267.04M | 8.81% |
| 2023 | $245.42M | -10.75% |
| 2022 | $274.99M | 27.30% |
| 2021 | $216.01M | 22.32% |
| 2020 | $176.59M | 1.90% |
| 2019 | $173.30M | 6.76% |
| 2018 | $162.33M | 15.38% |
| 2017 | $140.69M | 17.79% |
| 2016 | $119.44M | 13.00% |
| 2015 | $105.71M | -3.94% |
| 2014 | $110.04M | 32.38% |
| 2013 | $83.13M | 23.17% |
| 2012 | $67.49M | 26.76% |
| 2011 | $53.24M | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $46.34B | 14,424.25% |
US
|
|
| $25.11B | 7,769.91% |
US
|
|
| $2.71B | 748.55% |
US
|
|
| - | - |
CN
|
|
| $7.37B | 2,210.79% |
US
|
